News

NEW PUBLICATIONS

Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein–RNA Interaction of LIN28 and Let-7

Lydia Borgelt, Fu Li, Pascal Hommen, Philipp Lampe, Jimin Hwang, Georg L. Goebel, Sonja Sievers, and Peng Wu*
_{ACS Med. Chem. Lett. 2021, 12, 6, 893–898, March 1, 2021} more

Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex

Herbert Waldmann, Adrian Krzyzanowski, Raphael Gasper, Hélène Adihou, Peter’t Hart
_{First published: 24. February 2021} more

Multicomponent Petasis Reaction for the Synthesis of Functionalized 2-Aminothiophenes and Thienodiazepines

Jimin Hwang, Lydia Borgelt, and Peng Wu*
_{ACS Comb Sci. 2020 Oct. 12;22(10):495-499. doi:10.1021/acscombsci.0c00173. Epub 2020 Sep. 28} more

Dr. Peng Wu will receive research funding from the Exploration Grants programme

Peng Wu received the 2020SCT Award for Young Investigator in Medicinal Chemistry

Dr. Peng Wu receives research funding of approximately 120,000 euros for the development of innovative anti-corona therapeutics

VolkswagenStiftung supports corona research in Dortmund

Malte Gersch accepted to the Young College of the NRW Academy of Sciences, Humanities and the Art

Malte Gersch's team is looking for new ways to develop innovative therapeutic approaches.

CGC Symposium 2019 and Arrival of the 4. Group leader Dr. Jochen Imig at the CGC

Systems Biology of LncRNA and MiRNA Networks in Cancer

Malte Gersch, Group Leader at Chemical Genomics Centre

Dr. Malte Gersch

Peter 't Hart, Group Leader at Chemical Genomics Centre

Dr. Peter ‘t Hart received his bachelor degree in Chemistry from the Rotterdam University of Applied Sciences and went on to obtain his MSc degree from Utrecht University in Pharmacy.

Peng Wu, Group Leader at Chemical Genomics Centre

Dr. Peng Wu received his Doctoral Degree in Medicinal Chemistry from Zhejiang University in 2012. H